Change Language

Select Language

COVID-19
The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.

Viral Inactivation Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Market Overview:

The global viral inactivation market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to grow at a CAGR of around 11% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end-use sectors. These insights are included in the report as a major market contributor.

Biotherapeutic products contain viruses or they can become contaminated during the production process. Viruses are infectious particles that invade cells wherein they proliferate and result in various diseases. As a result, viral inactivation is widely used to inhibit coat proteins and degrade nucleic acid within the virus. At present, different methods of viral inactivation are available across the globe according to the characteristics of the virus and the type of biotherapeutic product. For instance, germicidal (UVC) light exposure helps inactivate viruses in hospitals and other critical public and military environments.

Viral Inactivation Market Trends:

Human blood is a source of medicinal products that assists in the prevention and treatment of life-threatening diseases. Rising concerns about the transmission of blood-borne viruses through plasma-derived medicinal products represent one of the significant factors influencing the need for viral inactivation around the world. Several procedures for viral inactivation are nowadays used to assure the safety of blood plasma-derived protein solutions. Moreover, governing agencies of numerous countries are introducing stringent regulatory standards at an early stage in the development of biotherapeutic products. These standards are escalating the demand for viral inactivation to ensure the quality, safety, and efficacy of these products, thereby reducing the risk of cross-contamination. Apart from this, improved viral inactivation technologies and products are being employed in the food and beverage (F&B) industry to help control the transmission of enteric viruses and assure the safety of products. This, in confluence with the development of new physical methods like supercritical fluids, gas plasma, and pulsed electric fields, is anticipated to increase the reliability, convenience, and suitability of viral inactivation, thereby driving the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global viral inactivation market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product, application and end use.

Breakup by Product:

  • Reagents and Kits
  • Systems
  • Services
     

Breakup by Application:

  • Vaccines and Therapeutics
  • Stem Cell Products
  • Blood and Blood Products
  • Tissue and Tissue Products
  • Cellular and Gene Therapy
     

Breakup by End Use:

  • Pharmaceutical and Biotechnology Companies
  • CROs
  • Academic and Research Institutes
  • Others
     

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa
     

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Charles River Laboratories, Merck KGaA, Parker Hannifin Corp, Rad Source Technologies, Sartorius AG, SGS SA, Terumo Corporation, Texcell, Vironova AB and WuXi AppTec.

Report Coverages:

Report Features Details
Base Year of the Analysis 2020
    Historical Period 2015-2020
Forecast Period 2021-2026
Units US$ Million
Segment Coverage Product, Application, End Use, Region
Region Covered  Asia Pacific, Europe, North America, Latin America, Middle East and Africa
Countries Covered United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico
Companies Covered Charles River Laboratories, Merck KGaA, Parker Hannifin Corp, Rad Source Technologies, Sartorius AG, SGS SA, Terumo Corporation, Texcell, Vironova AB and WuXi AppTec.
Customization Scope 10% Free Customization
Report Price and Purchase Option                                     Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

 

Key Questions Answered in This Report:

  • How has the global viral inactivation market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global viral inactivation market?
  • What are the key regional markets?
  • What is the breakup of the market based on the product?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the end use?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global viral inactivation market and who are the key players?
  • What is the degree of competition in the industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Viral Inactivation Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6    Market Breakup by Product
    6.1    Reagents and Kits
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Systems
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    Services
        6.3.1 Market Trends
        6.3.2 Market Forecast
7    Market Breakup by Application
    7.1    Vaccines and Therapeutics
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Stem Cell Products
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Blood and Blood Products
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Tissue and Tissue Products
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Cellular and Gene Therapy
        7.5.1 Market Trends
        7.5.2 Market Forecast
8    Market Breakup by End Use
    8.1    Pharmaceutical and Biotechnology Companies
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    CROs
        8.2.1 Market Trends
        8.2.2 Market Forecast
    8.3    Academic and Research Institutes
        8.3.1 Market Trends
        8.3.2 Market Forecast
    8.4    Others
        8.4.1 Market Trends
        8.4.2 Market Forecast
9    Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10    SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11    Value Chain Analysis
12    Porters Five Forces Analysis

    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13    Price Analysis
14    Competitive Landscape

    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Charles River Laboratories
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    Merck KGaA
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Parker Hannifin Corp
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Rad Source Technologies
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 SWOT Analysis
        14.3.5    Sartorius AG
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    SGS SA
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 Financials
        14.3.7    Terumo Corporation
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Texcell
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
        14.3.9    Vironova AB
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
        14.3.10    WuXi AppTec
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials

List of Figures

Figure 1: Global: Viral Inactivation Market: Major Drivers and Challenges
Figure 2: Global: Viral Inactivation Market: Sales Value (in Million US$), 2015-2020
Figure 3: Global: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 4: Global: Viral Inactivation Market: Breakup by Product (in %), 2020
Figure 5: Global: Viral Inactivation Market: Breakup by Application (in %), 2020
Figure 6: Global: Viral Inactivation Market: Breakup by End Use (in %), 2020
Figure 7: Global: Viral Inactivation Market: Breakup by Region (in %), 2020
Figure 8: Global: Viral Inactivation (Reagents and Kits) Market: Sales Value (in Million US$), 2015 & 2020
Figure 9: Global: Viral Inactivation (Reagents and Kits) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 10: Global: Viral Inactivation (Systems) Market: Sales Value (in Million US$), 2015 & 2020
Figure 11: Global: Viral Inactivation (Systems) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 12: Global: Viral Inactivation (Services) Market: Sales Value (in Million US$), 2015 & 2020
Figure 13: Global: Viral Inactivation (Services) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 14: Global: Viral Inactivation (Vaccines and Therapeutics) Market: Sales Value (in Million US$), 2015 & 2020
Figure 15: Global: Viral Inactivation (Vaccines and Therapeutics) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 16: Global: Viral Inactivation (Stem Cell Products) Market: Sales Value (in Million US$), 2015 & 2020
Figure 17: Global: Viral Inactivation (Stem Cell Products) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 18: Global: Viral Inactivation (Blood and Blood Products) Market: Sales Value (in Million US$), 2015 & 2020
Figure 19: Global: Viral Inactivation (Blood and Blood Products) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 20: Global: Viral Inactivation (Tissue and Tissue Products) Market: Sales Value (in Million US$), 2015 & 2020
Figure 21: Global: Viral Inactivation (Tissue and Tissue Products) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 22: Global: Viral Inactivation (Cellular and Gene Therapy) Market: Sales Value (in Million US$), 2015 & 2020
Figure 23: Global: Viral Inactivation (Cellular and Gene Therapy) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 24: Global: Viral Inactivation (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2015 & 2020
Figure 25: Global: Viral Inactivation (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 26: Global: Viral Inactivation (CROs) Market: Sales Value (in Million US$), 2015 & 2020
Figure 27: Global: Viral Inactivation (CROs) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 28: Global: Viral Inactivation (Academic and Research Institutes) Market: Sales Value (in Million US$), 2015 & 2020
Figure 29: Global: Viral Inactivation (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 30: Global: Viral Inactivation (Other End Uses) Market: Sales Value (in Million US$), 2015 & 2020
Figure 31: Global: Viral Inactivation (Other End Uses) Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 32: North America: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 33: North America: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 34: United States: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 35: United States: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 36: Canada: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 37: Canada: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 38: Asia-Pacific: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 39: Asia-Pacific: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 40: China: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 41: China: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 42: Japan: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 43: Japan: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 44: India: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 45: India: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 46: South Korea: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 47: South Korea: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 48: Australia: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 49: Australia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 50: Indonesia: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 51: Indonesia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 52: Others: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 53: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 54: Europe: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 55: Europe: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 56: Germany: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 57: Germany: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 58: France: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 59: France: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 60: United Kingdom: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 61: United Kingdom: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 62: Italy: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 63: Italy: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 64: Spain: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 65: Spain: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 66: Russia: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 67: Russia: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 68: Others: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 69: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 70: Latin America: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 71: Latin America: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 72: Brazil: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 73: Brazil: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 74: Mexico: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 75: Mexico: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 76: Others: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 77: Others: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 78: Middle East and Africa: Viral Inactivation Market: Sales Value (in Million US$), 2015 & 2020
Figure 79: Middle East and Africa: Viral Inactivation Market: Breakup by Country (in %), 2020
Figure 80: Middle East and Africa: Viral Inactivation Market Forecast: Sales Value (in Million US$), 2021-2026
Figure 81: Global: Viral Inactivation Industry: SWOT Analysis
Figure 82: Global: Viral Inactivation Industry: Value Chain Analysis
Figure 83: Global: Viral Inactivation Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Viral Inactivation Market: Key Industry Highlights, 2020 and 2026
Table 2: Global: Viral Inactivation Market Forecast: Breakup by Product (in Million US$), 2021-2026
Table 3: Global: Viral Inactivation Market Forecast: Breakup by Application (in Million US$), 2021-2026
Table 4: Global: Viral Inactivation Market Forecast: Breakup by End Use (in Million US$), 2021-2026
Table 5: Global: Viral Inactivation Market Forecast: Breakup by Region (in Million US$), 2021-2026
Table 6: Global: Viral Inactivation Market: Competitive Structure
Table 7: Global: Viral Inactivation Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Need more help?

  •   Speak to our experienced analysts for insights on the current market scenarios.
  •   Include additional segments and countries to customize the report as per your requirement.
  •   Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  •   For further assistance, please connect with our analysts.

Purchase Options




$ 2299

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )


Drop us an email at

sales@imarcgroup.com

Social Links